ARID4B and prostate adenocarcinoma: Results revealed that expression of ARID4B was higher in prostate adenocarcinoma compared to prostate hyperplasia (Fig. 6a, left), shown as an increase in the number of ARID4B-positive cells in prostate adenocarcinoma samples (Fig. 6c, left and Supplementary Fig. 11a, left).